Burn and plug: is it too much for the left atrial appendage?
نویسندگان
چکیده
منابع مشابه
A Semi-Automated Algorithm for Segmentation of the Left Atrial Appendage Landing Zone: Application in Left Atrial Appendage Occlusion Procedures
Background: Mechanical occlusion of the Left atrial appendage (LAA) using a purpose-built device has emerged as an effective prophylactic treatment in patients with atrial fibrillation at risk of stroke and a contraindication for anticoagulation. A crucial step in procedural planning is the choice of the device size. This is currently based on the manual analysis of the “Device Landing Zone” fr...
متن کاملElectrical Isolation of the Left Atrial Appendage: Is It Safe?
Pulmonary vein isolation is an accepted cornerstone for all atrial fibrillation (AF) ablation. This is true for both paroxysmal and persistent AF, although other atrial structures have been demonstrated to be involved in the initiation and maintenance of AF, including the left atrial appendage (LAA). Di Biase et al, demonstrated that the LAA may be responsible for AF recurrence in a subset of p...
متن کاملPercutaneous vascular plug for incomplete surgical left atrial appendage closure.
Surgical left atrial appendage (LAA) exclusion has a failure rate as high as 60% due to persistent residual flow in the LAA or large LAA remnants. We describe a novel technique for treatment of incomplete surgical LAA ligation, and define the mechanism that led to persistence of the remnant LAA without any thrombus formation.
متن کاملIs it all too much?
I couldn’t help but notice the recent press reports of how the weather was going to be dealt with for the 2008 Beijing Olympics. Having picked the wettest month of the year to hold the Olympic Games, the Chinese have developed one of the world’s largest weather modification strategies. Weather patterns over Beijing in recent decades indicate a 50% chance of rain during the Games. Clearly, this ...
متن کاملHow much atrial fibrillation is too much atrial fibrillation?
n engl j med 366;2 nejm.org january 12, 2012 178 tive anti-HER2 agents as adjuvant therapies may translate into metastatic disease developing in fewer patients. Given the success of the pivotal trials of adjuvant trastuzumab therapy, clinical trials of adjuvant therapies, which are already large and expensive, will by necessity require even more subjects to detect small differences with a new a...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Journal of Interventional Cardiac Electrophysiology
سال: 2019
ISSN: 1383-875X,1572-8595
DOI: 10.1007/s10840-019-00644-6